🇺🇸 FDA
Patent

US 9783586

Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 9783586 (Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K38/00, A61K38/1709, A61K45/06